Filing Details
- Accession Number:
- 0001214659-18-004614
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-28 19:00:26
- Reporting Period:
- 2018-06-26
- Accepted Time:
- 2018-06-28 19:00:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599324 | Jamie Christensen | C/O Mirati Therapeutics, Inc. 9393 Towne Centre Drive, Ste 200 San Diego CA 92121 | Svp, Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-26 | 5,208 | $5.40 | 8,085 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-26 | 4,058 | $48.62 | 4,027 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-26 | 1,150 | $49.27 | 3,394 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-06-27 | 4,999 | $5.50 | 8,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-27 | 4,234 | $49.43 | 4,159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-27 | 736 | $50.15 | 3,423 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-27 | 29 | $51.33 | 3,394 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-06-26 | 5,208 | $0.00 | 5,208 | $5.40 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-06-27 | 4,999 | $0.00 | 4,999 | $5.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,292 | 2027-01-25 | No | 4 | M | Direct | |
| 17,502 | 2026-10-26 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2017.
- This transaction was executed in multiple trades at prices ranging from $48.05 to $49.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $49.05 to $49.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $48.90 to $49.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $49.90 to $50.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 517 shares acquired under the ESPP Purchase on 05/31/18.
- 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
Billionaire Hedge Funds
